Results 191 to 200 of about 78,261 (320)

Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?

International Journal of Cancer, Volume 157, Issue 5, Page 964-979, 1 September 2025.
What's new? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart, Lars Tögel, Maria Giulia Carta, Philip Hetzner, Lina Helbig, Charlotte Zaglas, Maria Ziegler, Robert Stöhr, Annett Hölsken, Juliane Hoyer, Fulvia Ferrazzi, Clemens Neufert, Sebastian Lettmaier, Marianne Pavel, Henriette Golcher, Sarina K. Mueller, Florian Fuchs, Carla E. Schulmeyer, Matthias W. Beckmann, Bernd Wullich, Abbas Agaimy, Andre Reis, Arndt Hartmann, Norbert Meidenbauer, Silvia Spoerl, Florian Haller, Evgeny A. Moskalev   +26 more
wiley   +1 more source

Up-regulation of thrombospondin-1 inhibits the progression of gallbladder cancer. [PDF]

Med Oncol
Shu C, Zhou H, Xu J, Tang J, Zhou S.
europepmc   +1 more source

RETRACTED: Laparoscopic cholecystectomy and unsuspected gallbladder cancer

, 2001
F. Romano, Chiara Franciosi, Roberto Caprotti, Sergio De Fina, G Porta, G Visintini, Fabio Uggeri   +6 more
openalex   +1 more source

An innovative benefit‐of‐the‐doubt approach for health system effectiveness: a global case study on amenable mortality

International Transactions in Operational Research, Volume 32, Issue 5, Page 2847-2877, September 2025.
Abstract Health system performance assessment (HSPA) is essential for health planning and to improve population health. One of the HSPA domains is related to effectiveness, which can be represented considering different dimensions. Composite indicators can be used to summarize complex constructs involving several indicators. One example of such efforts
Giovanna D'Inverno, João Vasco Santos, Ana S. Camanho   +2 more
wiley   +1 more source

Establishment and characterization of a new human gallbladder cancer cell line, OCUG-2. [PDF]

World J Exp Med
Wang Q, Fan C, Tsujio G, Sakuma T, Maruo K, Yamamoto Y, Imanishi D, Kawabata K, Nishikubo H, Kanei S, Aoyama R, Kushiyama S, Ohira M, Yashiro M.   +13 more
europepmc   +1 more source

Coexistence of Xanthogranulomatous Cholecystitis and Gallbladder Cancer. A Case Report.

, 2001
Jun Kadono, Nobuo Hamada, Mamoru Kaieda, Naoki Ishizaki, Noboru Nakamura, Mikio Fukueda, Yasuyo Ooi, Akira Ikoma, Ryuzo Sakata   +8 more
openalex   +2 more sources

Fucoidan From Brown Algae as a Functional Food Ingredient: A Promising Anticancer Agent

eFood, Volume 6, Issue 4, August 2025.
Fucoidan, a bioactive polysaccharide from brown algae, inhibits receptor tyrosine kinase (RTK) activation and vascular endothelial growth factor (VEGF) signaling, suppressing the phosphoinositide 3‐kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) and RAS/RAF/mitogen‐activated protein kinase/extracellular signal‐regulated kinase ...
Muhammad Umer Khan, Iqra Khurram, Maha Munir, Muhammad Ikram Ullah, Heba Bassiony Ghanem, Javad Sharifi‐Rad, William N. Setzer, Daniela Calina   +7 more
wiley   +1 more source

Role and mechanism of sarcosine dehydrogenase in the progression of gallbladder cancer through chemokine pathways. [PDF]

World J Gastrointest Oncol
Gao Z, Zhang X, He H.
europepmc   +1 more source

A Case of Xanthogranulomatous Cholecystitis with Portal Venous Thrombosis and Early Gallbladder Cancer.

, 2001
Takashi Kato, Yoshiaki Tsuchiya, Yutaka YABUSAKI, Atsushi Nashimoto, Otsuo Tanaka   +4 more
openalex   +2 more sources

Gallbladder cancer worldwide: Geographical distribution and risk factors [PDF]

, 2006
G. Randi, Silvia Franceschi, Carlo La Vecchia   +2 more
openalex   +1 more source